HOW IT WORKS
The pulsed magnetic field penetrates the body evenly, unaffected and alters rapidly, it is generated and disappeared in very short time. According to Faraday's law about induction, a disappearing magnetic field leaves behind in its place a circular electric field. In that way, deep inside a tissue electric fileds and "eddy currents" are induced.
The device can be safely and effectively used in the following medical conditions:
• Non-specific low back pain
• Osteoarthritis
• Rotator cuff tendinopathy
• Patellofemoral pain syndrome
• Bone fracture
• Achilles tendinopathy
• Chronic aseptic osteitis pubis
• Geriatric depression
• Benign prostate hyperplasia
The device may be used in combination with any other relevant and applicable method.
Users that are not medical professionals must first consult a Health Care Professional in order to receive proper guidance and instructions regarding alignment of the medical condition with the intended use of the device and specific way of application.
CONTRAINDICATIONS
• Patients carrying or are implanted with any type/model of electronic devices (e.g., pacemaker,
Cochlear Implants, insulin pumps, hearing aids, etc)
• Patients with implants of any size and material that are incompatible with magnetic fields (i.e.,
not labelled as “MR-safe”)
• Hypotension
• Internal bleeding
• Pregnant women
• Patients with transplanted organs
So far, no adverse effect by the application of the Papimi Series device has been reported and the results are only positive. Finally, the fact that magnetotherapy does not cause temperature raise of the exposed tissues must be underlined.
References
• Krath A, Klüter T, Stukenberg M, Zielhardt P, Gollwitzer H, Harrasser N, et al. Electromagnetic transduction therapy in nonspecific
low back pain: A prospective randomised controlled trial. J Orthop. 2017;14: 410–415. doi:10.1016/j.jor.2017.06.016
• Klüter T, Krath A, Stukenberg M, Gollwitzer H, Harrasser N, Knobloch K, et al. Electromagnetic transduction therapy and
shockwave therapy in 86 patients with rotator cuff tendinopathy: A prospective randomized controlled trial. Electromagn Biol
Med. 2018;37: 175–183. doi:10.1080/15368378.2018.1499030
• Giannakopoulos XK, Giotis C, Karkabounas SC, Verginadis II, Simos Y V, Peschos D, et al. Effects of pulsed electromagnetic
fields on benign prostate hyperplasia. Int Urol Nephrol. 2011;43: 955–960. doi:10.1007/s11255-011-9944-7
• Leblhuber F, Steiner K, Gostner J, Fuchs D. Repetitive transcranial magnetic stimulation in patients with late life depression
influences phenylalanine metabolism. Pteridines. 2018;29: 87–90. doi:10.1515/pteridines-2018-0008
• Markovic L, Wagner B, Crevenna R. Effects of pulsed electromagnetic field therapy on outcomes associated with osteoarthritis: A
systematic review of systematic reviews. Wien Klin Wochenschr. 2022;134: 425–433. doi:10.1007/s00508-022-02020-3
• Yang X, Medicine R, He H, Medicine R, Ye W, Medicine R, et al. Effects of pulsed electromagnetic field therapy on pain, stiffness,
physical function, and quality of life in patients with osteoarthritis: a systematic review and meta-analysis of randomized placebocontrolled
trials. Phys Ther. 2020;100: 1118–1131.
• Cappon D, den Boer T, Jordan C, Yu W, Metzger E, Pascual-Leone A. Transcranial magnetic stimulation (TMS) for geriatric
depression. Ageing Res Rev. 2022;74: 101531. doi:10.1016/j.arr.2021.101531
• Griffin XL, Warner F, Costa M. The role of electromagnetic stimulation in the management of established non-union of long bone
fractures: What is the evidence? Injury. 2008;39: 419–429. doi:10.1016/j.injury.2007.12.014
• Saltychev M, Dutton RA, Laimi K, Beaupre GS, Virolainen P, Fredericson M. Effectiveness of conservative treatment for
patellofemoral pain syndrome: A systematic review and meta-analysis. J Rehabil Med. 2018;50: 393–401.
doi:10.2340/16501977-2295
• Peng L, Fu C, Xiong F, Zhang Q, Liang Z, Chen L, et al. Effectiveness of Pulsed Electromagnetic Fields on Bone Healing: A
Systematic Review and Meta-Analysis of Randomized Controlled Trials. Bioelectromagnetics. 2020;41: 323–337.
doi:10.1002/bem.22271
